Clayton RN - Search Results

1

Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.

Abdu TA, Elhadd TA, Buch H, Barton D, Neary R, Clayton RN. Abdu TA, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2004 Sep;61(3):387-93. doi: 10.1111/j.1365-2265.2004.02109.x. Clin Endocrinol (Oxf). 2004. PMID: 15355457 Clinical Trial.

2

Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.

Abdu TA, Elhadd TA, Neary R, Clayton RN. Abdu TA, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 1999 Mar;84(3):838-43. doi: 10.1210/jcem.84.3.5535. J Clin Endocrinol Metab. 1999. PMID: 10084558 Clinical Trial.

3

Endothelial dysfunction in endocrine disease.

Abdu TA, Elhadd T, Pfeifer M, Clayton RN. Abdu TA, et al. Among authors: clayton rn. Trends Endocrinol Metab. 2001 Aug;12(6):257-65. doi: 10.1016/s1043-2760(01)00425-8. Trends Endocrinol Metab. 2001. PMID: 11445443 Review.

4

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.

Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN. Abdu TA, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2001 Aug;55(2):209-16. doi: 10.1046/j.1365-2265.2001.01320.x. Clin Endocrinol (Oxf). 2001. PMID: 11531927

5

Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.

Elhadd TA, Abdu TA, Oxtoby J, Kennedy G, McLaren M, Neary R, Belch JJ, Clayton RN. Elhadd TA, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 2001 Sep;86(9):4223-32. doi: 10.1210/jcem.86.9.7813. J Clin Endocrinol Metab. 2001. PMID: 11549653 Clinical Trial.

6

Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults.

Abdu TA, Elhadd TA, Akber M, Hartland A, Neary R, Clayton RN. Abdu TA, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2001 Nov;55(5):635-8. doi: 10.1046/j.1365-2265.2001.01364.x. Clin Endocrinol (Oxf). 2001. PMID: 11894975

7

Pituitary tumours are multiclonal from the outset: evidence from a case with dural metastases.

Buch H, El-Hadd T, Bicknell J, Simpson DJ, Farrell WE, Clayton RN. Buch H, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2002 Jun;56(6):817-22. doi: 10.1046/j.1365-2265.2002.01524.x. Clin Endocrinol (Oxf). 2002. PMID: 12072054

8

Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis.

Buch HN, Raskauskiene D, Bahar A, Bicknell EJ, Farrell WE, Clayton RN. Buch HN, et al. Among authors: clayton rn. Clin Endocrinol (Oxf). 2004 Jul;61(1):19-25. doi: 10.1111/j.1365-2265.2004.02046.x. Clin Endocrinol (Oxf). 2004. PMID: 15212640

9

Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions.

Elhadd TA, Neary R, Abdu TA, Kennedy G, Hill A, McLaren M, Akber M, Belch JJ, Clayton RN. Elhadd TA, et al. Among authors: clayton rn. Int Angiol. 2003 Sep;22(3):222-8. Int Angiol. 2003. PMID: 14612848

10

Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.

Rajkhowa M, Neary RH, Kumpatla P, Game FL, Jones PW, Obhrai MS, Clayton RN. Rajkhowa M, et al. Among authors: clayton rn. J Clin Endocrinol Metab. 1997 Oct;82(10):3389-94. doi: 10.1210/jcem.82.10.4318. J Clin Endocrinol Metab. 1997. PMID: 9329374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters